Experience | Leaflets | Diagrams | Medicines | Support | Patient+ | Guidelines | Weblinks | Poems | Videos | News | Products | Other
This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Which Device in Asthma
Post your experienceSee others (10 there)
The ideal way to deliver drugs in asthma or COPD is by inhalation. A standard dose of salbutamol for inhalation is 100 micrograms compared with 2 or 4 mg in tablet form. Hence if drugs can be delivered directly to the lung they will act faster and at a lower dose (20 to 40-fold in the case of salbutamol) which will reduce the incidence of side-effects. However, if the device fails to deliver the drug to the correct place it is of no value at all.
There are a variety of devices available but they can be classified generically as metered dose inhalers (MDI), MDI with spacers, dry powder inhalers (DPI), breath-actuated MDIs (BA-MDI) and nebulisers.
The anatomy of the airways is such that particles tend to be filtered out before they reach the lungs but small particles between 1 and 7 µm in diameter1 will reach the relevant parts. Larger particles will be filtered out higher up. The speed of the particles and the competence of the inhaler technique are also important.
Metered dose inhalers (MDI)
MDIs are the standard mechanism for delivering drugs to the small airways in asthma or COPD. However, it is essential that the patient is educated in the use of the device and that this competence is checked.2
As well as education, adequate coordination is required. This must be checked and not assumed. Lack of coordination between activation of the device and inspiration is a major cause of failure of these devices and it is not limited to children.3 It is the main cause of poorly controlled asthma.1 If used properly a MDI is at least as effective as any other form of delivery and much cheaper.4 An American review of the evidence concluded that MDIs are no more or less effective that other systems of delivery and so the least expensive should be chosen.5 However, if a cheaper system fails to deliver the drug it is very poor value.
Because of the phasing out of CFCs other propellants have been developed for these inhalers and the evidence suggests that they are just as efficient as the old type.6 In fact, a study using a human upper airway model linked to a computer suggests that CFC-free inhalers, combined with a smaller nozzle (0.25 mm instead of 0.5 mm) may be more efficient because it produces smaller droplets.7
The dosage of CFC-free beta agonist inhalers is equivalent to CFC-containing inhalers.
The dosage of CFC-free steroid inhalers may be different from those which contained CFCs. For further information see Inhaled Corticosteroids.
Spacers with MDI
Most spacers are of large volume, around 750 ml, made of plastic and they are inconvenient to carry around. Smaller spacers exist but are probably less effective although this is disputed.8 Large spacers usually have a valve system that permits the drug to stay in suspension whilst it is inhaled. The dose may be reduced by accumulation of electrostatic charge so that the drug is absorbed on to the plastic. This can be avoided by periodic washing of the device in soapy water or detergent.
Spacer devices slow down the particles and make coordination of actuation and inhalation much less critical. The main advantage of the spacers is that they increase the proportion of the dose delivered to the airways (where the drugs produce the desired effect), while reducing the proportion absorbed into the body (which is usually the cause of unwanted effects). Metered dose inhalers with large volume spacers deposit at least 30% more drug in the lung but deposit 60% less drug in the patient, because of reduced oropharyngeal deposition.
Any drug that gets into the body but not into the lungs is undesirable. Beta agonists cause tremor and tachycardia. Steroid inhalers can produce oropharyngeal candidiasis and systemic side effects of steroids, including retardation of growth in children.
Bandolier gives the following table to show this effect.9,10,11,12
Pattern of Drug Deposition with Different Inhalers (values are % of total drug dose) |
|||
| Site of Deposition | Dry powder inhaler | Metered dose inhaler | MDI with large volume spacer |
| Lung | 10-15% | 10-15% | 20% |
| Oropharynx | 80% | 80% | 15% |
| Device (total) |
5% | 5% | 65% |
| Patient (total) |
95% | 95% | 35% |
The British Thoracic Society (BTS) guidelines recommend the use of a MDI plus spacer in preference to a nebuliser for the treatment of a mild to moderate acute asthma attack.13 This approach is also supported by a Cochrane review which pointed out that this combination is much cheaper than a nebuliser and does not need a source of power.14 It is also noise-free and may be less scarey for small children.
The guidelines state that there are insufficient data to make recommendations about the use of nebulisers in life-threatening asthma, but later they do recommend that oxygen-driven nebulisers should be used to deliver high-dose beta-agonists in the management of a severe asthma attack.
The BTS recommend MDI plus spacer for the treatment of stable asthma in children and adults, for the delivery of both beta agonists and steroids.
Benefits from the use of large volume spacers include:
- More effective treatment with fewer side-effects because of better pattern of deposition
- Problems of poor inhaler technique largely overcome but spacers need to be used properly too
- Easily used by children and the elderly (except those with weak or arthritic hands)
- As effective as a nebuliser in treatment of acute attacks but light, cheap, maintenance free, portable and available on prescription
- Useful for treatment of first attacks of wheezing in patients who have not used inhalers before
- Useful for administration of bronchodilator when testing reversibility in the surgery to establish the diagnosis of asthma
- Reduced prescribing costs by basing treatment on the much cheaper metered dose inhalers
Cough after use of a spacer and MDI is a poorly understood problem that may affect compliance. In one study it affected 30% of children after beta agonists and 54.5% of children after a steroid inhalation.15
Dry powder inhalers (DPI)
These devices can be as small and portable as a MDI but requiring less coordination. Drug delivery to the lungs is dependent upon the patient's peak inhaled flow rate. They are more expensive than MDI plus spacer and BTS guidelines state that they are no more effective. However, they may be preferred by some patients. The most recent devices will still be under patent. The BTS guidelines state that newer DPIs are no more effective than older types.13
DPIs do not have any propellant, whether CFC or otherwise. Sometimes patients complain that they are not certain if they have taken a dose and devices may be discarded well before they are empty.
Breath-actuated metered dose inhalers (BA-MDI)
These allow patients to prime the inhaler and when the patient takes a breath the inhaler is activated. This avoids the need to coordinate release of the metered dose with breathing. BA-MDs are as effective as MDIs.13 They can be used as second line inhaler devices if there are co-ordination problems with the MDIs after full instruction.
Nebulisers
The BTS guidelines state that there is insufficient evidence to make recommendations about the use of nebulisers in the emergency situation but as mentioned above, they do recommend their use in severe asthma attacks. There is furthermore there is insufficient data to recommend nebulisers in standard therapy, although some patients prefer to use them. Nebulisers are no longer recommended as first-line treatment for acute asthma.13
A wide variety of nebulisers are available. Conventional jet nebulisers waste a great deal of the drug during expiration. Breath assisted open vent systems have considerably reduced this but it is dependent upon the patient having an adequate expiratory flow.
Ultrasonic nebulisers produce a high mass output and have a shorter time for treatment but are inefficient for delivering suspensions or viscous liquids. Adaptive aerosol delivering devices release a precise dose that is tailored to the individual's breathing pattern.16
Both nebulisers and spacers used for small children employ facemasks. There are some significant differences between the characteristics of the various masks affecting efficacy.
It is essential to choose the device that is most suited to the patient.
In as many as 50% of cases asthma is poorly controlled.17
The BTS guidelines do not recommend any particular order of inhaler, should a patient have problems using a standard MDI. They advise considering the following points:
- The choice of device may be determined by the choice of drug.
- If the patient is unable to use a device satisfactorily an alternative should be found.
- The patient should have their ability to use an inhaler device assessed by a competent healthcare professional.
- The medication needs to be titrated against clinical response to ensure optimum efficacy.
- In children aged 0-5 years, pMDI and spacer are the preferred method of delivery of beta agonists. A face mask is required until the child can breathe reproducibly using the spacer mouthpiece. Where this is ineffective a nebuliser may be required.
The BTS guidelines also make recommendations about the use and care of spacers:
- The spacer should be compatible with the pMDI being used.
- The drug should be administered by repeated single actuations of the metered dose inhaler into the spacer, each followed by inhalation.
- There should be minimal delay between pMDI actuation and inhalation.
- Tidal breathing is as effective as single breaths.
- Spacers should be cleaned monthly rather than weekly as per manufacturer's recommendations or performance is adversely affected.They should be washed in detergent and allowed to dry in air. The mouthpiece should be wiped clean of detergent before use.
- Drug delivery may vary significantly due to static charge. Metal and other antistatic spacers are not affected in this way.
- Plastic spacers should be replaced at least every 12 months but some may need changing at six months.
Document references
- Everard ML; Role of inhaler competence and contrivance in "difficult asthma". Paediatr Respir Rev. 2003 Jun;4(2):135-42. [abstract]
- Munzenberger PJ, Thomas R, Bahrainwala A; Retention by children of device technique for inhaled asthma drugs between visits. J Asthma. 2007 Nov;44(9):769-73. [abstract]
- Rodriguez M, Celay E, Larrea I, et al; Inhalation techniques in the treatment of asthma. An Sist Sanit Navar. 2003;26 Suppl 2:139-46. [abstract]
- Brocklebank D, Ram F, Wright J, et al; Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5(26):1-149. [abstract]
- Kallstrom TJ; Evidence-based asthma management. Respir Care. 2004 Jul;49(7):783-92. [abstract]
- Woodcock A, Williams A, Batty L, et al; Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant. J Aerosol Med. 2002 Winter;15(4):407-14. [abstract]
- Kleinstreuer C, Shi H, Zhang Z; Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology. J Aerosol Med. 2007 Fall;20(3):294-309. [abstract]
- Nagel MW, Wiersema KJ, Bates SL, et al; Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler. J Aerosol Med. 2002 Winter;15(4):427-33. [abstract]
- Bandolier; Drug watch - large volume spacers in asthma
- Keeley D; Large volume plastic spacers in asthma. BMJ. 1992 Sep 12;305(6854):598-9.
- Keeley D; How to achieve better outcome in treatment of asthma in general practice. BMJ. 1993 Nov 13;307(6914):1261-3. [abstract]
- Jones KP, Bain DJ, Middleton M, et al; Correlates of asthma morbidity in primary care. BMJ. 1992 Feb 8;304(6823):361-4. [abstract]
- British Guideline on the Management of Asthma, British Thoracic Society and SIGN (May 2008)
- Cates CC, Bara A, Crilly JA, et al; Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2003;(3):CD000052. [abstract]
- Dubus JC, Mely L, Huiart L, et al; Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma. Fundam Clin Pharmacol. 2003 Oct;17(5):627-31. [abstract]
- De Benedictis FM, Selvaggio D; Use of inhaler devices in pediatric asthma. Paediatr Drugs. 2003;5(9):629-38. [abstract]
- General Practice Airways Group (GPIAG).; The professional website for GPs, practice nurses and allied healthcare professionals.
Internet and further reading
- Guidelines for the prevention, identification and management of occupational asthma: evidence review and recommendations, British Occupational Health Research Foundation (2004)
Document ID: 490
Document Version: 4
Document Reference: bgp24500
Last Updated: 18 Jul 2008
Planned Review: 18 Jul 2010
The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.
Patient UK Hearing Impairment Survey
Patient UK are grateful to the 550 people who took part in this survey.
To see the results click here.
If you'd like to leave your feedback, please go to our interactive forum.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Asthma Inhalers' (10 there)Health Topic information leaflets related to this topic (^ top of page)
Asthma
Asthma - Peak Flow Diary
Asthma - Peak Flow Meter
Asthma - Picture Summary
Inhalers for Asthma
Inhalers for Chronic Obstructive Pulmonary Disease (COPD)Diagrams related to this topic (^ top of page)
Lung - asthma attack (diagram)
Peak Flow Diary (diagram)Medicine & Drug information leaflets related to this topic (^ top of page)
FormoterolSupport Groups related to this topic (^ top of page)
Asthma UK
British Lung Foundation
European Federation of Asthma and Allergy AssociationPatientPlus articles related to this topic (^ top of page)
Acute Severe Asthma and Status Asthmaticus
Antileukotrienes
Asthma Action Plans
Breathlessness
Bronchial Asthma
Diagnosing Childhood Asthma in Primary Care
Inhaled Corticosteroids
Management Of Adult Asthma
Management of Childhood Asthma
Nebulisers in General Practice
Occupational Asthma
Peak Flow Recording
Spirometry
Spirometry Calculator
Wheezing in childrenUK guidelines related to this topic (^ top of page)
Guidelines on AsthmaLinks to other selected websites related to this topic (^ top of page)
AsthmaPoems and stories related to this topic (^ top of page)
Beating Asthma
Billy's Wheezy Chest
Meet the Asthma Nurse
Vlad the ImpalerVideos related to this topic (^ top of page)
Links to online videos on AsthmaPatient UK Newspaper (^ top of page)
Recent related news items
Oxygen therapy in swine flu
'I was too fat to walk up the stairs'
Asthma Most Common Condition In Hospitalized Swine Flu Patients - Washington Post
Scots more allergic than English
Inhaler 'can worsen asthma for children'All news by related topic
Asthma newsRelated Products (^ top of page)
Medical equipment
Medical Bracelets
Nebulisers
Pill/Tablet Equipment
Books
Asthma - A Simple Guide
Asthma - Best Medicine for Asthma
Asthma (Living with)
Asthma : British Medical Association's Family Doctor Series
Asthma Explained: A Guide for Patients and Carers
Asthma: Answers At Your Fingertips (4th Edition)
Living with Asthma
Other - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites
Want to search some more? Use the Google Search box below to search our site.
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window



